These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3030363)

  • 1. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
    Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
    Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated?
    Sala PG; Mazzolini S; Tonutti E; Crucil C; Pitzus E; Bramezza M
    Boll Ist Sieroter Milan; 1987; 66(1):14-7. PubMed ID: 3040040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of antibodies against HTLV-III in the at risk population in Madrid. Clinical study and incidence of virologic markers].
    González Lahoz JM; Gutiérrez Angulo MT; Polo Rodríguez R; Subirats Núñez M; Moreno Celda V; Baquero Mochales M
    Rev Clin Esp; 1987 May; 180(8):416-9. PubMed ID: 3649830
    [No Abstract]   [Full Text] [Related]  

  • 4. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
    Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
    Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
    [No Abstract]   [Full Text] [Related]  

  • 6. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of neonates from transfusion-associated AIDS by the use of CMV-seronegative blood before availability of specific serologic tests for HTLV-III (HIV).
    Brady MT; Ng A
    Am J Perinatol; 1987 Oct; 4(4):305-7. PubMed ID: 2820434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
    Antinori A; Tamburrini E; Ventura G; Nervo P; Ortona L
    Boll Ist Sieroter Milan; 1988; 67(5-6):345-50. PubMed ID: 2908738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
    Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
    J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III.
    Crapper RM; Frazer IH; Mackay IR; Iscaro A; Bradford DL
    Concepts Immunopathol; 1987; 4():243-60. PubMed ID: 3297337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.